Form 8-K COLGATE PALMOLIVE CO For: Jan 31

Go back to Form 8-K COLGATE PALMOLIVE CO For: Jan 31

TD Cowen Reiterates Buy Rating on Colgate-Palmolive Company (CL)

February 3, 2025 1:18 PM EST

TD Cowen analyst Robert Moskow reiterated a Buy rating and $100.00 price target on Colgate-Palmolive Company (NYSE: CL).

The analyst comments "4Q gross margin expanded 70 bps, materially slower than the 290 bps in the last three quarters, because the transactional FX amplified cost inflation and... More

Barclays Reiterates Equalweight Rating on Colgate-Palmolive Company (CL)

February 3, 2025 6:49 AM EST

Barclays analyst Lauren R. Lieberman reiterated an Equalweight rating and $83.00 price target on Colgate-Palmolive Company (NYSE: CL)

The analyst comments "Given Colgate's greater exposure to emerging markets (~50% of total company sales), it has benefited disproportionately versus its Staples peers, from inflationary pricing (a ~10.5%... More

Raymond James Reiterates Outperform Rating on Colgate-Palmolive Company (CL)

January 31, 2025 8:50 AM EST

Raymond James analyst Olivia Tong reiterated an Outperform rating and $110.00 price target on Colgate-Palmolive Company (NYSE: CL)

The analyst comments "CL reported 4Q results this morning, and while organic sales and margins missed, below-the-line expenses were lower than expected, resulting in an EPS beat ($0.91 vs. our $0.90 and StreetAccount/BBG consensus $0.89). Organic sales... More